160 related articles for article (PubMed ID: 35183716)
1. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.
Togami K; Ogasawara A; Irie S; Iwata K; Yamaguchi K; Tada H; Chono S
Eur J Pharm Biopharm; 2022 Mar; 172():203-212. PubMed ID: 35183716
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized Liposomal Formulation Prevents Enhanced Drug Transfer from Fibrotic Lungs to the Systemic Circulation.
Togami K; Kurasho K; Kanehira Y; Tada H; Chono S
Curr Drug Deliv; 2021; 18(7):947-954. PubMed ID: 33372874
[TBL] [Abstract][Full Text] [Related]
3. Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis.
Togami K; Kanehira Y; Yumita Y; Ozaki H; Wang R; Tada H; Chono S
J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):289-299. PubMed ID: 37843890
[No Abstract] [Full Text] [Related]
4. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
Celebioglu A; Uyar T
J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
[TBL] [Abstract][Full Text] [Related]
5. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
6. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
Togami K; Chono S; Tada H
J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
[TBL] [Abstract][Full Text] [Related]
7. Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis.
Togami K; Maruta Y; Nanbu M; Tada H; Chono S
Drug Dev Ind Pharm; 2020 Nov; 46(11):1873-1880. PubMed ID: 32940095
[TBL] [Abstract][Full Text] [Related]
8. Inhaled nintedanib is well-tolerated and delivers key pharmacokinetic parameters required to treat bleomycin-induced pulmonary fibrosis.
Surber MW; Beck S; Pham S; Marsden AT; Gandi SK; Baily J; McElroy MC
Pulm Pharmacol Ther; 2020 Aug; 63():101938. PubMed ID: 32841676
[TBL] [Abstract][Full Text] [Related]
9. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
10. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
11. Effects of nintedanib on the microvascular architecture in a lung fibrosis model.
Ackermann M; Kim YO; Wagner WL; Schuppan D; Valenzuela CD; Mentzer SJ; Kreuz S; Stiller D; Wollin L; Konerding MA
Angiogenesis; 2017 Aug; 20(3):359-372. PubMed ID: 28283856
[TBL] [Abstract][Full Text] [Related]
12. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of curcumin wound healing ability by complexation with 2-hydroxypropyl-γ-cyclodextrin in sacran hydrogel film.
Wathoni N; Motoyama K; Higashi T; Okajima M; Kaneko T; Arima H
Int J Biol Macromol; 2017 May; 98():268-276. PubMed ID: 28161536
[TBL] [Abstract][Full Text] [Related]
14. Fyn-kinase and caveolin-1 in the alveolar epithelial junctional adherence complex contribute to the early stages of pulmonary fibrosis.
Menzel V; Ziegler M; Hante N; Sake JA; Santos-Martinez MJ; Ehrhardt C; Kasper M; Barth K
Eur J Pharm Sci; 2022 Aug; 175():106236. PubMed ID: 35710078
[TBL] [Abstract][Full Text] [Related]
15. Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs.
Celebioglu A; Uyar T
Food Chem; 2020 Jul; 317():126397. PubMed ID: 32078994
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
[TBL] [Abstract][Full Text] [Related]
17. Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction.
Yu WK; Chen WC; Su VY; Shen HC; Wu HH; Chen H; Yang KY
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897764
[TBL] [Abstract][Full Text] [Related]
18. Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.
Hesse C; Beneke V; Konzok S; Diefenbach C; Bülow Sand JM; Rønnow SR; Karsdal MA; Jonigk D; Sewald K; Braun A; Leeming DJ; Wollin L
Respir Res; 2022 Aug; 23(1):201. PubMed ID: 35927669
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis.
Chen WC; Chen NJ; Chen HP; Yu WK; Su VY; Chen H; Wu HH; Yang KY
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630825
[TBL] [Abstract][Full Text] [Related]
20. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
